Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-13003873Phase 4Completed
Phase 4, randomised, open-label trial of kangai injection in gastrointestinal neoplasia (2 arms), sponsored by Guang'anmen Hospital. Primary endpoints: Clinical symptoms, Quality of life and 2 more. Started Apr 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-13003873.